Abstract:ASD (Autism Spectrum Disorders) are NDDs (Neurodevelopmental Disorders) with complex etiology including multiple genetic and environmental factors.Non-coding mutations contribute to the multifactorial etiology of ASD by influencing gene activity through various regulatory mechanisms. Advances in genomic technologies, such as whole-genome sequencing (WGS) and chromatin interaction studies, have highlighted the role of non-coding regions in ASD genetics.Identifying these non-coding variants enhances our understanding of the underlying complex genetic landscape ASD. This study aims to analyze the impact of non-coding mutations within regulatory regions in Autism Spectrum Disorder (ASD). The research builds upon a cohort of 360 Spanish ASD trios, from which 200 trios were selected after excluding cases with known copy number variants (CNVs) and whole-exome sequencing (WES) mutations. The selection process intentionally enhanced the sample for undiscovered non-coding risk variants by excluding cases with de novo loss-of-function mutations or large de novo CNVs. To identify regulatory regions of interest, the study employed targeting sequencing of a selection of candidate cis-regulatory elements (cCREs) from ENCODE v2. De novo variation and rare inherited variation were studied using different bioinformatic pipelines and their impact on regulatory activities was assessed using a deep-learning approach (Sei framework). Additional analysis including candidate gene elucidation using ATAC-seq and PLAC-seq data in neuronal cells, variant prioritization, protein-protein interaction (PPI) network,Transcription Factor (TF) enrichment, presence in topologically associated domains (TADs) were also carried out. Sex bias in regulatory variation within ASD was also explored in our analysis.We discovered that 28% of de novo variants and 25% of inherited variants with high regulatory potential were found in patients with negative results from whole-exome sequencing (WES) and microarray analyses, as assessed by Sei. By integrating PLAC-Seq data, we functionally annotated approximately 80% of de novo variants and 85% of inherited variants. While resources like ENCODE provide valuable insights into genomic regulatory elements, it is crucial to be cautious when prioritizing specific regulatory elements based on initial hypotheses regarding their impact on gene regulation: many sequence classes associated with ASD in this study did not show significant enrichment in any particular cCRE signature. Notably, the most important observation in this study is the implication of a global dysregulation of CTCF suggesting a potential mechanistic impact on the chromatin architecture. In addition,We have found that the most high-impact regulatory variants-whether de novo or inherited-are linked to genes not previously associated with ASD. Nevertheless, gene ontology (GO) enrichments indicate that both coding and non-coding variations likely interact within already characterized ASD pathways.

Noncoding de novo mutations in are associated with autism spectrum disorders

Contribution of de novo non-coding mutations to autism and identification of risk genes from whole-genome sequencing of affected families

Genome-wide characteristics of de novo mutations in autism

Detection of Clinically Relevant Genetic Variants in Autism Spectrum Disorder by Whole-Genome Sequencing

The contribution of de novo coding mutations to autism spectrum disorder

Correction: Nonrandom Occurrence of Multiple De Novo Coding Variants in a Proband Indicates the Existence of an Oligogenic Model in Autism

De novo genic mutations among a Chinese autism spectrum disorder cohort

Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder

Vitamin D-related genes are subjected to significant de novo mutation burdens in autism spectrum disorder.

Deciphering the Non-Coding Genome in Autism Spectrum Disorders (ASD): A Study of De Novo and Rare Inherited Variants through Targeted Sequencing in Regulatory Regions

Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model

Genomic analysis of 116 autism families strengthens known risk genes and highlights promising candidates

De Novo Insertions and Deletions of Predominantly Paternal Origin Are Associated with Autism Spectrum Disorder.

Identification of De Novo Mutations in the Chinese Autism Spectrum Disorder Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation

Patterns and rates of exonic de novo mutations in autism spectrum disorders

Genome-wide Analyses of Exonic Copy Number Variants in a Family-Based Study Point to Novel Autism Susceptibility Genes.

Whole-genome sequencing identifies novel genes for autism in Chinese trios

Association Between De Novo Variants of Nuclear-Encoded Mitochondrial-Related Genes and Undiagnosed Developmental Disorder and Autism.

Analysis of recent shared ancestry in a familial cohort identifies coding and noncoding autism spectrum disorder variants

Targeted Sequencing Identifies 91 Neurodevelopmental Disorder Risk Genes with Autism and Developmental Disability Biases